Research, deployments, regulatory updates, and company news about PANCREASaver®.
PanCAD.ai has released an official introduction to PANCREASaver®, showing how AI-assisted review fits the contrast-enhanced abdominal CT workflow.
For product and educational information; AI outputs are reviewed by healthcare professionals.
Watch on YouTube ↗
Economic Daily reports that a hospital in southern Taiwan has adopted PANCREASaver® to add AI-assisted review of abdominal CT scans to its imaging and health checkup workflows, with suspicious pancreatic findings reviewed by physicians.
Source: Economic Daily · Original report in Chinese
As of October 13, 2026, PanCAD.ai reports that PANCREASaver® has been used in more than 5,500 patient cases across research and commercial applications.
Storm Media’s AI Healthcare Innovation Awards recognized PANCREASaver® among applications focused on healthcare innovation and earlier pancreatic cancer review.
Director Kai-Chun Yang and Dr. Wei-Chih Liao discuss how PANCREASaver® enters clinical practice while fitting existing physician workflows.
At Asian Pacific Digestive Week, the team presented real-world data from more than 2,000 CT studies analyzed in clinical practice.
PanCAD.ai announced partnerships with health centers to explore AI-assisted pancreatic CT review within routine abdominal checkup programs.
PANCREASaver® continues discussions with international institutions; the portfolio includes 10 patents in Taiwan and the U.S.
National recognition brings the portfolio to nine awards, including the RSNA Margulis Award, SNQ, Taipei BioTech, and National Innovation Award.
The study appeared in the peer-reviewed journal Radiology and provides an independent reference for the algorithm’s research basis.
PANCREASaver® is used across Taiwan medical centers and regional hospitals, supporting radiology teams through an evidence-based workflow.